Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Carcinoma, Basal Cell

triazoles has been researched along with Carcinoma, Basal Cell in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL1
Chang, LS; Hu, WP; Kuo, KK; Senadi, GC; Wang, JJ1
Chau, LQ; Dash, RC; Hadden, MK; Morel, SR; Teske, KA; Wechsler-Reya, RJ1
Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL1
Chen, B; Epstein, EH; Kim, J; Lee, A; Tang, JY; Trang, V; Williams, NS; Wilson, AN1
Alfonsi, R; Brunetti, M; Colaceci, F; Di Marcotullio, L; Filocamo, G; Lahm, A; Mancuso, M; Pasquali, E; Pazzaglia, S; Saran, A; Sasso, R; Steinkühler, C; Tanori, M1
Brown, M; O'Reilly Zwald, F1
Megahed, M; Reifenberger, J; Schulte, KW; Sonntag, M1
DiLeonardo, M; Gibbons, G; Resnik, KS1

Reviews

1 review(s) available for triazoles and Carcinoma, Basal Cell

ArticleYear
Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2

    Topics: Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Education, Medical, Continuing; Female; Humans; Immunocompromised Host; Incidence; Male; Melanoma; Organ Transplantation; Prognosis; Pyrimidines; Risk Assessment; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2011

Other Studies

8 other study(ies) available for triazoles and Carcinoma, Basal Cell

ArticleYear
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    JAMA dermatology, 2020, 07-01, Volume: 156, Issue:7

    Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole

2020
Photodynamic Therapy Using Indolines-Fused-Triazoles Induces Mitochondrial Apoptosis in Human Non-Melanoma BCC Cells.
    Anticancer research, 2017, Volume: 37, Issue:10

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Survival; Humans; Indoles; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Time Factors; Triazoles

2017
Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors.
    European journal of medicinal chemistry, 2019, Feb-01, Volume: 163

    Topics: Antifungal Agents; Carcinoma, Basal Cell; Hedgehog Proteins; Humans; Molecular Dynamics Simulation; Protein Binding; Signal Transduction; Smoothened Receptor; Structure-Activity Relationship; Triazoles

2019
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult

2013
Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:5

    Topics: Animals; Antifungal Agents; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Disease Models, Animal; Gene Knockout Techniques; Hedgehog Proteins; Humans; Mice; Signal Transduction; Skin Neoplasms; Smoothened Receptor; Triazoles; Xenograft Model Antitumor Assays

2016
MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Cycle; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Isoxazoles; Medulloblastoma; Mice; Neoplasm Transplantation; Random Allocation; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays

2016
[Ulcus terebrans. Therapy options and their limits].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:10

    Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Debridement; Female; Humans; Incidental Findings; Neoplasm Staging; Neoplasms, Multiple Primary; Nitriles; Palliative Care; Radioisotope Teletherapy; Scalp; Skin Neoplasms; Skin Ulcer; Triazoles

2004
Clinically occult cutaneous metastases.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing

2006